|
1
|
Agarwal S, Sane R, Oberoi R, Ohlfest JR
and Elmquist WF: Delivery of molecularly targeted therapy to
malignant glioma, a disease of the whole brain. Expert Rev Mol Med.
13:e172011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Delgado-López PD and Corrales-García EM:
Survival in glioblastoma: A review on the impact of treatment
modalities. Clin Transl Oncol. 18:1062–1071. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yan W, Zhang W and Jiang T: Oncogene
addiction in gliomas: Implications for molecular targeted therapy.
J Exp Clin Cancer Res. 30:582011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jia L, Tian Y, Chen Y and Zhang G: The
silencing of LncRNA-H19 decreases chemoresistance of human glioma
cells to temozolomide by suppressing epithelial-mesenchymal
transition via the Wnt/β-catenin pathway. Onco Targets Ther.
11:313–321. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang Q, Du X, Yang M, Xiao S, Cao J, Song
J and Wang L: LncRNA ZEB1-AS1 contributes to STAT3 activation by
associating with IL-11 in B-lymphoblastic leukemia. Biotechnol
Lett. 39:1801–1810. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lin J, Zhan Y, Liu Y, Chen Z, Liang J, Li
W, He A, Zhou L, Mei H, Wang F, et al: Increased expression of
ZEB1-AS1 correlates with higher histopathological grade and
promotes tumorigenesis in bladder cancer. Oncotarget.
8:24202–24212. 2017.PubMed/NCBI
|
|
7
|
Li T, Xie J, Shen C, Cheng D, Shi Y, Wu Z,
Deng X, Chen H, Shen B, Peng C, et al: Upregulation of long
noncoding RNA ZEB1-AS1 promotes tumor metastasis and predicts poor
prognosis in hepatocellular carcinoma. Oncogene. 35:1575–1584.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gong H, Wen H, Zhu X, Lian Y, Yang X, Qian
Z and Zhu J: High expression of long non-coding RNA ZEB1-AS1
promotes colorectal cancer cell proliferation partially by
suppressing p15 expression. Tumour Biol. 39:10104283177053362017.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang YL, Bai Y, Yao WJ, Guo L and Wang ZM:
Expression of long non-coding RNA ZEB1-AS1 in esophageal squamous
cell carcinoma and its correlation with tumor progression and
patient survival. Int J Clin Exp Pathol. 8:11871–11876.
2015.PubMed/NCBI
|
|
10
|
Rong L, Zhao R and Lu J: Highly expressed
long non-coding RNA FOXD2-AS1 promotes non-small cell lung cancer
progression via Wnt/β-catenin signaling. Biochem Biophys Res
Commun. 484:586–591. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li Y, Wen X, Wang L, Sun X, Ma H, Fu Z and
Li L: LncRNA ZEB1-AS1 predicts unfavorable prognosis in gastric
cancer. Surg Oncol. 26:527–534. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lv QL, Hu L, Chen SH, Sun B, Fu ML, Qin
CZ, Qu Q, Wang GH, He CJ and Zhou HH: A long noncoding RNA ZEB1-AS1
promotes tumorigenesis and predicts poor prognosis in glioma. Int J
Mol Sci. 17:172016. View Article : Google Scholar
|
|
13
|
Fu J and Cui Y: Long noncoding RNA
ZEB1-AS1 expression predicts progression and poor prognosis of
colorectal cancer. Int J Biol Markers. 32:e428–e433. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bonavia R, Inda MM, Vandenberg S, Cheng
SY, Nagane M, Hadwiger P, Tan P, Sah DW, Cavenee WK and Furnari FB:
EGFRvIII promotes glioma angiogenesis and growth through the NF-κB,
interleukin-8 pathway. Oncogene. 31:4054–4066. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li J, Li Z, Leng K, Xu Y, Ji D, Huang L,
Cui Y and Jiang X: ZEB1-AS1: A crucial cancer-related long
non-coding RNA. Cell Prolif. 51:e124232018. View Article : Google Scholar
|
|
16
|
Su W, Xu M, Chen X, Chen N, Gong J, Nie L,
Li L, Li X, Zhang M and Zhou Q: Long noncoding RNA ZEB1-AS1
epigenetically regulates the expressions of ZEB1 and downstream
molecules in prostate cancer. Mol Cancer. 16:1422017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fang C, Zan J, Yue B, Liu C, He C and Yan
D: Long non-coding ribonucleic acid zinc finger antisense 1
promotes the progression of colonic cancer by modulating ZEB1
expression. J Gastroenterol Hepatol. 32:1204–1211. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang S, Wang W, Liu G, Xie S, Li Q, Li Y
and Lin Z: Long non-coding RNA HOTTIP promotes hypoxia-induced
epithelial-mesenchymal transition of malignant glioma by regulating
the miR-101/ZEB1 axis. Biomed Pharmacother. 95:711–720. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu C, Pan C, Cai Y and Wang H: Interplay
between long noncoding RNA ZEB1-AS1 and miR-200s regulates
osteosarcoma cell proliferation and migration. J Cell Biochem.
118:2250–2260. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lenting K, Verhaak R, Ter Laan M,
Wesseling P and Leenders W: Glioma: Experimental models and
reality. Acta Neuropathol. 133:263–282. 2017. View Article : Google Scholar : PubMed/NCBI
|
